University of Health Sciences
Ankara, Keçiören, 06010, Turkey (Türkiye)
NCT Number: NCT06778876
Today, psychophysiological insomnia is the most common persistent insomnia. Lavender essential oil is frequently used in the literature as an aromatherapy method to improve sleep quality. Studies have found that lavender improves sleep quality. They also emphasized that more studies are needed in this area. When the relevant literature is reviewed, no studies examining the effects of lavender oil on patients with psychophysiological insomnia were found. In this context, the aim of the study was to evaluate the effect of lavender on sleep quality and insomnia severity in patients with psychophysiological insomnia.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Ankara, Keçiören, 06010, Turkey (Türkiye)
Today, psychophysiological insomnia is the most common persistent insomnia. The patient's inability to sleep occurs as a result of repetitive negative thoughts such as the thought that he will have difficulty sleeping before going to bed and/or past experiences involving the bedroom or the night. More effort to sleep causes more wakefulness and more difficulty falling asleep.
Numerous studies have shown that insomnia seriously affects health and quality of life and can cause various problems including memory problems, depression, irritability, cardiovascular and cerebrovascular diseases, etc. Therefore, looking for effective ways to improve sleep quality is important for individual and social health. Today, drug therapy, psychotherapy, physiotherapy and cognitive-behavioral therapy are widely used treatments for insomnia. Recently, more and more studies have found that aromatherapy is one of the non-drug treatments to improve sleep quality. Lavender essential oil appears in the literature as an aromatherapy method frequently used to improve sleep quality.
Studies have found that lavender improves sleep quality. They also emphasized that more studies are needed in this area. When the relevant literature was examined, no studies were found examining the effects of lavender oil on patients with psychophysiological insomnia. In this context, the aim of the study was to evaluate the effect of lavender on sleep quality and insomnia severity in patients with psychophysiological insomnia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The normal procedure applied in the sleep clinic (keeping a sleep diary, sleep hygiene education) will be followed and participants will be asked to sleep with lavender sachets inside their pillows for two weeks.
Participants will follow the normal procedure applied (keeping a sleep diary, sleep hygiene training) in the sleep clinic and no additional intervention will be performed.
Time frame: two weeks
PSQI is a 19-item scale, assessed by self-report (19 items) and spouse/roommate responses (5 items). The scale includes components such as sleep quality, duration, and disturbance, and the total score ranges from 0 to 21; a score greater than 5 indicates poor sleep quality.
Time frame: two weeks
ISS is a 7-item self-report scale. The total score obtained from this scale varies between 0 and 28, and a score of 15 and above indicates clinical insomnia.
Time frame: two weeks
ESS is a four-point Likert-type scale consisting of 8 items. The score range of this scale is 0 to 24, and a score of 10 and above indicates excessive daytime sleepiness.
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Other
Effect of Lavender on Sleep Quality and Insomnia Severity in Patients With Psychophysiological Insomnia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04598672
Chronic Disease, Disease Attributes
Oslo, Norway
View Trial DetailsNCT05723211
Behavior, Dyssomnias
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04598425
Anxiety Disorders, Behavior
Oslo, Norway
View Trial DetailsNCT03673397
Behavior, Behavioral Symptoms
Sankt Gallen, Switzerland
View Trial Details